Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

433 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Active, Not Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +8 more
Locations
  • The Universtity of Arizona Arthrtis Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cleveland Clinic - Florida Weston, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +27 more
Locations
  • Keck School of Medicine of University of Southern California Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Lurie Children's; Northwestern Medicine - Northwestern Medical Group Chicago, Illinois, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of MT-0551 in Patients With Systemic Sclerosis

NCT05198557

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • University of Fukui Hospital Yoshida-gun, Fukui, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • St. Marianna University Hospital Kawasaki-shi, Kanagawa, Japan
  • The University of Tokyo Hospital Bunkyo-ku, Tokyo, Japan
View Trial Details

Related conditions